Forbigående kuldegysninger, feber eller influenzalignende sygdom blev rapporteret at forekomme timer efter doseringen (hos henholdsvis 3%, 2% og 1% af patienterne).
Transient chills, fever or influenza like illness were reported to occur hours after dosing (in 3%, 2% and 1% of patients, respectively).